• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射频消融治疗后最初诊断为良性的甲状腺结节中癌症的延迟诊断:超声特征和癌症预测因素。

Delayed Cancer Diagnosis in Thyroid Nodules Initially Treated as Benign With Radiofrequency Ablation: Ultrasound Characteristics and Predictors for Cancer.

机构信息

Department of Radiology and Center for Imaging Science, Thyroid Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

Korean J Radiol. 2023 Sep;24(9):903-911. doi: 10.3348/kjr.2023.0386.

DOI:10.3348/kjr.2023.0386
PMID:37634644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10462893/
Abstract

OBJECTIVE

Regrowth after radiofrequency ablation (RFA) of symptomatic large thyroid nodules, initially treated as benign, sometimes turns out to be malignancies. This study aimed to assess the ultrasound (US) characteristics of thyroid nodules initially treated as benign with RFA and later diagnosed as cancers, predictive factors for cancers masquerading as benign, and methods to avoid RFA in these cancers.

MATERIALS AND METHODS

We reviewed the medical records of 134 consecutive patients with 148 nodules who underwent RFA between February 2008 and November 2016 for the debulking of symptomatic thyroid nodules diagnosed as benign using US-guided biopsy. We investigated the pre-RFA characteristics of the thyroid nodules, changes at follow-up after RFA, and the final surgical pathology.

RESULTS

Nodule regrowth after RFA was observed in 36 (24.3%) of the 148 benign nodules. Twenty-two of the 36 nodules were surgically removed, and malignancies were confirmed in seven (19.4% of 36). Of the 22 nodules removed surgically, pre-RFA median volume (range) was significantly larger for malignant nodules than for benign nodules: 22.4 (13.9-84.5) vs. 13.4 (7.3-16.8) mL ( = 0.04). There was no significant difference in the regrowth interval between benign and malignant nodules ( = 0.49). The median volume reduction rate (range) at 12 months was significantly lower for malignant nodules than for benign nodules (51.4% [0-57.8] vs. 83.8% [47.9-89.6]) ( = 0.01). The pre-RFA benignity of all seven malignant nodules was confirmed using two US-guided fine-needle aspirations (FNAs), except for one nodule, which was confirmed using US-guided core-needle biopsy (CNB). Regrown malignant nodules were diagnosed as suspicious follicular neoplasms by CNB. Histological examination of the malignant nodules revealed follicular thyroid carcinomas, except for one follicular variant, a papillary thyroid carcinoma.

CONCLUSION

Symptomatic large benign thyroid nodules showing regrowth or suboptimal reduction after RFA may have malignant potential. The confirmation of these nodules is better with CNB than with FNA.

摘要

目的

射频消融(RFA)治疗后,最初被诊断为良性的有症状的大甲状腺结节会出现复发,其中有些结节最终被诊断为恶性肿瘤。本研究旨在评估经 RFA 治疗的最初被诊断为良性、但后来被诊断为癌症的甲状腺结节的超声(US)特征、表现为良性的癌症的预测因素,以及避免对这些癌症进行 RFA 的方法。

材料和方法

我们回顾了 2008 年 2 月至 2016 年 11 月期间因超声引导下活检诊断为良性的有症状甲状腺结节而接受 RFA 减瘤治疗的 134 例连续患者的病历资料,共 148 个结节。我们研究了 RFA 前甲状腺结节的特征、RFA 后随访时的变化,以及最终的手术病理。

结果

在 148 个良性结节中,有 36 个(24.3%)在 RFA 后出现结节复发。36 个结节中有 22 个进行了手术切除,其中 7 个(36 个的 19.4%)被证实为恶性肿瘤。在 22 个手术切除的结节中,恶性结节的 RFA 前中位体积(范围)明显大于良性结节:22.4(13.9-84.5)与 13.4(7.3-16.8)mL( = 0.04)。良性和恶性结节的复发间隔无显著差异( = 0.49)。12 个月时,恶性结节的中位体积减少率(范围)明显低于良性结节(51.4%[0-57.8]与 83.8%[47.9-89.6])( = 0.01)。除 1 个结节外,其余 7 个恶性结节的术前均经两次超声引导下细针抽吸活检(FNA)证实为良性,该结节经超声引导下核心针活检(CNB)证实为良性。复发性恶性结节经 CNB 诊断为可疑滤泡性肿瘤。对恶性结节的组织学检查显示,除 1 例为甲状腺滤泡癌的滤泡变异型外,其余均为甲状腺滤泡癌。

结论

射频消融(RFA)治疗后出现复发或效果不佳的有症状大良性甲状腺结节可能具有恶性潜能。这些结节采用 CNB 诊断优于 FNA。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91bf/10462893/dcc35966b332/kjr-24-903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91bf/10462893/5af2517f999b/kjr-24-903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91bf/10462893/dcc35966b332/kjr-24-903-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91bf/10462893/5af2517f999b/kjr-24-903-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91bf/10462893/dcc35966b332/kjr-24-903-g002.jpg

相似文献

1
Delayed Cancer Diagnosis in Thyroid Nodules Initially Treated as Benign With Radiofrequency Ablation: Ultrasound Characteristics and Predictors for Cancer.射频消融治疗后最初诊断为良性的甲状腺结节中癌症的延迟诊断:超声特征和癌症预测因素。
Korean J Radiol. 2023 Sep;24(9):903-911. doi: 10.3348/kjr.2023.0386.
2
Cytomorphological changes in thyroid nodules induced by radiofrequency ablation therapy: Emphasis on recurrent papillary thyroid carcinoma.射频消融治疗引起的甲状腺结节细胞形态学变化:重点关注复发性甲状腺乳头状癌。
Ann Diagn Pathol. 2025 Aug;77:152479. doi: 10.1016/j.anndiagpath.2025.152479. Epub 2025 Apr 5.
3
Ultrasound-Pathology Discordant Nodules on Core-Needle Biopsy: Malignancy Risk and Management Strategy.粗针活检中超声与病理结果不一致的结节:恶性风险及管理策略
Thyroid. 2017 May;27(5):707-713. doi: 10.1089/thy.2016.0462. Epub 2017 Mar 22.
4
Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.超声检查提示甲状腺结节可疑,且最初的细胞学检查结果为良性:核心针穿刺活检的作用。
Thyroid. 2013 Jun;23(6):703-8. doi: 10.1089/thy.2012.0426. Epub 2013 May 28.
5
Laser Ablation Versus Radiofrequency Ablation for Benign Non-Functioning Thyroid Nodules: Six-Month Results of a Randomized, Parallel, Open-Label, Trial (LARA Trial).激光消融与射频消融治疗良性非功能性甲状腺结节:一项随机、平行、开放标签临床试验(LARA 试验)的 6 个月结果。
Thyroid. 2020 Jun;30(6):847-856. doi: 10.1089/thy.2019.0660. Epub 2020 Mar 17.
6
Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience.良性甲状腺结节射频消融治疗的预测因素分析:单中心经验。
Front Endocrinol (Lausanne). 2021 May 17;12:638880. doi: 10.3389/fendo.2021.638880. eCollection 2021.
7
Ultrasonography-guided core needle biopsy for the thyroid nodule: does the procedure hold any benefit for the diagnosis when fine-needle aspiration cytology analysis shows inconclusive results?超声引导下甲状腺结节细针穿刺活检:当细针抽吸细胞学分析结果不确定时,该操作对诊断有何益处?
Br J Radiol. 2013 May;86(1025):20130007. doi: 10.1259/bjr.20130007.
8
Long-Term Results of Ultrasound-Guided Radiofrequency Ablation of Benign Thyroid Nodules: State of the Art and Future Perspectives-A Systematic Review.超声引导下射频消融良性甲状腺结节的长期疗效:现状与未来展望——系统综述。
Front Endocrinol (Lausanne). 2021 May 26;12:622996. doi: 10.3389/fendo.2021.622996. eCollection 2021.
9
Safety and Efficacy of Ultrasound-Guided Radiofrequency Ablation for Benign Nonfunctional Thyroid Nodules in Children: A Retrospective Study of 62 Patients with Over Four Years of Follow-Up.超声引导下射频消融治疗儿童良性非功能性甲状腺结节的安全性和疗效:一项超过四年随访的 62 例患者的回顾性研究。
Thyroid. 2022 May;32(5):525-535. doi: 10.1089/thy.2021.0454. Epub 2022 Jan 17.
10
Solid benign thyroid nodules (>10 ml): a retrospective study on the efficacy and safety of sonographically guided ethanol ablation combined with radiofrequency ablation.实性良性甲状腺结节 (>10ml):超声引导下乙醇消融联合射频消融的疗效和安全性的回顾性研究。
Int J Hyperthermia. 2020;37(1):157-167. doi: 10.1080/02656736.2020.1717647.

引用本文的文献

1
Prevalence and diagnostic reliability of BRAF, RAS mutations, and RET/PTC rearrangements in a Latin American public health service population with thyroid nodular disease.拉丁美洲公共卫生服务体系中甲状腺结节性疾病患者BRAF、RAS基因突变及RET/PTC重排的患病率与诊断可靠性
PLoS One. 2025 Aug 1;20(8):e0329407. doi: 10.1371/journal.pone.0329407. eCollection 2025.
2
Anaplastic and poorly differentiated thyroid carcinomas at intervention sites: implications of track seeding and the importance of follow-up monitoring- report of two cases.干预部位的间变性和低分化甲状腺癌:针道种植的影响及随访监测的重要性——两例报告
Eur Arch Otorhinolaryngol. 2025 Jun;282(6):3357-3361. doi: 10.1007/s00405-025-09281-4. Epub 2025 Mar 14.
3

本文引用的文献

1
2021 Korean Thyroid Imaging Reporting and Data System and Imaging-Based Management of Thyroid Nodules: Korean Society of Thyroid Radiology Consensus Statement and Recommendations.2021 年韩国甲状腺影像报告和数据系统及基于影像学的甲状腺结节管理:韩国甲状腺放射学会共识声明和建议。
Korean J Radiol. 2021 Dec;22(12):2094-2123. doi: 10.3348/kjr.2021.0713. Epub 2021 Oct 26.
2
Diagnostic Performance of the Modified Korean Thyroid Imaging Reporting and Data System for Thyroid Malignancy: A Multicenter Validation Study.改良版韩国甲状腺影像报告和数据系统对甲状腺恶性肿瘤的诊断性能:一项多中心验证研究。
Korean J Radiol. 2021 Sep;22(9):1579-1586. doi: 10.3348/kjr.2021.0230. Epub 2021 Jun 1.
3
Radiofrequency Ablation of Benign Thyroid Nodules: 10-Year Follow-Up Results From a Single Center.
良性甲状腺结节的射频消融:单中心10年随访结果
Korean J Radiol. 2025 Feb;26(2):193-203. doi: 10.3348/kjr.2024.0599.
4
Long-term clinical outcomes of thermal ablation for benign thyroid nodules and unresolved issues: a comprehensive systematic review.良性甲状腺结节热消融的长期临床结果及未解决的问题:一项全面的系统评价
Radiol Med. 2025 Jan;130(1):111-120. doi: 10.1007/s11547-024-01924-6. Epub 2024 Nov 18.
5
Thermal ablation for Bethesda III and IV thyroid nodules: current diagnosis and management.贝塞斯达Ⅲ级和Ⅳ级甲状腺结节的热消融:当前的诊断与管理
Ultrasonography. 2024 Nov;43(6):395-406. doi: 10.14366/usg.24083. Epub 2024 Aug 5.
6
A 6-year single-center prospective follow-up study of the efficacy of radiofrequency ablation for thyroid nodules.6 年单中心前瞻性随访研究射频消融治疗甲状腺结节的疗效。
Front Endocrinol (Lausanne). 2024 Jun 25;15:1402380. doi: 10.3389/fendo.2024.1402380. eCollection 2024.
7
Inquiries Regarding "Delayed Cancer Diagnosis in Thyroid Nodules Initially Treated as Benign With Radiofrequency Ablation: Ultrasound Characteristics and Predictors for Cancer".关于“甲状腺结节最初经射频消融治疗被视为良性但出现延迟癌症诊断:超声特征及癌症预测因素”的咨询
Korean J Radiol. 2024 Jan;25(1):116-117. doi: 10.3348/kjr.2023.0918.
8
Response: Inquiries Regarding "Delayed Cancer Diagnosis in Thyroid Nodules Initially Treated as Benign With Radiofrequency Ablation: Ultrasound Characteristics and Predictors for Cancer".回应:关于“最初经射频消融治疗被视为良性的甲状腺结节的癌症延迟诊断:超声特征及癌症预测因素”的咨询
Korean J Radiol. 2024 Jan;25(1):118-119. doi: 10.3348/kjr.2023.0974.
Comparison of the diagnostic performance of the modified Korean Thyroid Imaging Reporting and Data System for thyroid malignancy with three international guidelines.
改良版韩国甲状腺影像报告和数据系统对甲状腺恶性肿瘤的诊断性能与三项国际指南的比较。
Ultrasonography. 2021 Oct;40(4):594-601. doi: 10.14366/usg.21056. Epub 2021 Apr 5.
4
Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma: Analysis of cause of under- or misdiagnoses.术前细针穿刺细胞学诊断在组织学证实的甲状腺滤泡性腺瘤和癌,以及 Hurthle 细胞腺瘤和癌中的作用:误诊或漏诊原因分析。
PLoS One. 2020 Nov 4;15(11):e0241597. doi: 10.1371/journal.pone.0241597. eCollection 2020.
5
Radiofrequency ablation of benign thyroid nodules: recommendations from the Asian Conference on Tumor Ablation Task Force.良性甲状腺结节的射频消融:亚洲肿瘤消融会议特别工作组的建议
Ultrasonography. 2021 Jan;40(1):75-82. doi: 10.14366/usg.20112. Epub 2020 Sep 8.
6
Ultrasound-guided fine-needle aspiration or core needle biopsy for diagnosing follicular thyroid carcinoma?超声引导下细针抽吸活检或核心针活检用于诊断滤泡甲状腺癌?
Clin Endocrinol (Oxf). 2020 May;92(5):468-474. doi: 10.1111/cen.14167. Epub 2020 Feb 25.
7
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group.良性甲状腺结节的微创治疗:基于意大利甲状腺微创治疗(MITT)小组的德尔菲共识声明。
Int J Hyperthermia. 2019;36(1):376-382. doi: 10.1080/02656736.2019.1575482. Epub 2019 Mar 26.
8
Efficacy of radiofrequency ablation in autonomous functioning thyroid nodules. A systematic review and meta-analysis.射频消融治疗自主功能性甲状腺结节的疗效:系统评价和荟萃分析。
Rev Endocr Metab Disord. 2019 Mar;20(1):37-44. doi: 10.1007/s11154-019-09487-y.
9
False negative rate of fine-needle aspiration in thyroid nodules: impact of nodule size and ultrasound pattern.甲状腺结节细针穿刺的假阴性率:结节大小和超声模式的影响。
Head Neck. 2019 Apr;41(4):967-973. doi: 10.1002/hed.25530. Epub 2019 Feb 10.
10
Radiofrequency ablation of thyroid nodules: "Good Clinical Practice Recommendations" for Austria : An interdisciplinary statement from the following professional associations: Austrian Thyroid Association (ÖSDG), Austrian Society for Nuclear Medicine and Molecular Imaging (OGNMB), Austrian Society for Endocrinology and Metabolism (ÖGES), Surgical Endocrinology Working Group (ACE) of the Austrian Surgical Society (OEGCH).甲状腺结节的射频消融术:奥地利“良好临床实践建议”:来自以下专业协会的多学科声明:奥地利甲状腺协会(ÖSDG)、奥地利核医学与分子影像学会(OGNMB)、奥地利内分泌与代谢学会(ÖGES)、奥地利外科学会(OEGCH)的外科内分泌学工作组(ACE)。
Wien Med Wochenschr. 2020 Feb;170(1-2):6-14. doi: 10.1007/s10354-019-0682-2. Epub 2019 Feb 6.